2MOT

Backbone Structure of Actin Depolymerizing Factor (ADF) of Toxoplasma gondii Based on Prot3DNMR Approach

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
2	3D CBCA(CO)NH	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
3	3D C(CO)NH	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
4	3D HNCO	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
5	3D HNCA	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
6	(4,3)D-HNCN	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298
7	CNH-NOESY	10 % [U-99% 2H] D2O-1, 90 % H2O-2, 0.02 % sodium azide-3, 50 mM sodium phosphate-4, 150 mM sodium chloride-5, 1 mM EDTA-6	90% H2O/10% D2O	0.2	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
torsion angle dynamics, simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	The structure was determined using a combination of Dihedral angles and NOEs

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.